DK0474733T3 - Antihyperlipidæmiske og antiatherosklerotiske urinstofforbindelser - Google Patents

Antihyperlipidæmiske og antiatherosklerotiske urinstofforbindelser

Info

Publication number
DK0474733T3
DK0474733T3 DK90908860.1T DK90908860T DK0474733T3 DK 0474733 T3 DK0474733 T3 DK 0474733T3 DK 90908860 T DK90908860 T DK 90908860T DK 0474733 T3 DK0474733 T3 DK 0474733T3
Authority
DK
Denmark
Prior art keywords
antiatherosclerotic
antihyperlipidemic
urea compounds
cholesterol
thiourea
Prior art date
Application number
DK90908860.1T
Other languages
English (en)
Inventor
Bharat Kalidas Trivedi
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK0474733T3 publication Critical patent/DK0474733T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90908860.1T 1989-06-01 1990-05-31 Antihyperlipidæmiske og antiatherosklerotiske urinstofforbindelser DK0474733T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/359,830 US5015644A (en) 1987-06-02 1989-06-01 Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds

Publications (1)

Publication Number Publication Date
DK0474733T3 true DK0474733T3 (da) 1994-11-21

Family

ID=23415467

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90908860.1T DK0474733T3 (da) 1989-06-01 1990-05-31 Antihyperlipidæmiske og antiatherosklerotiske urinstofforbindelser

Country Status (12)

Country Link
US (1) US5015644A (da)
EP (1) EP0474733B1 (da)
JP (1) JP2799242B2 (da)
AT (1) ATE110713T1 (da)
AU (1) AU5675990A (da)
CA (1) CA2054209C (da)
DE (1) DE69012116T2 (da)
DK (1) DK0474733T3 (da)
IE (1) IE64603B1 (da)
PT (1) PT94231A (da)
WO (1) WO1990015048A1 (da)
ZA (1) ZA904231B (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
IL100915A (en) * 1991-02-19 1996-03-31 Erba Carlo Spa Disubstituted ureas and thioureas their preparation and pharmaceutical compositions containing them
FR2679555B1 (fr) * 1991-07-25 1993-11-19 Fabre Medicament Pierre Nouveaux derives de l'uree, leur preparation et leur application en therapeutique.
EP0642498A1 (en) * 1992-05-28 1995-03-15 Pfizer Inc. NEW $i(N)-ARYL AND $i(N)-HETEROARYLUREA DERIVATIVES AS INHIBITORS OF ACYL COENZYME A:CHOLESTEROL ACYL TRANSFERASE (ACAT)
AU672699B2 (en) * 1993-06-30 1996-10-10 Sankyo Company Limited Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
US5362744A (en) * 1993-11-22 1994-11-08 Warner-Lambert Company Tetrazole-substituted urea acat inhibitors
US5441984A (en) * 1994-01-06 1995-08-15 Eli Lilly And Company Urea, thiourea and guanidine derivatives
US5461049A (en) * 1994-05-27 1995-10-24 Warner-Lambert Company Amide tetrazole ACAT inhibitors
US6133326A (en) 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
EP0742208A1 (en) * 1995-05-05 1996-11-13 Grelan Pharmaceutical Co., Ltd. 2-Ureido-benzamide derivatives
CA2253502A1 (en) * 1996-05-06 1997-11-13 Stephen Warren Kaldor Anti-viral compounds
EP0811600A3 (en) * 1996-05-06 1998-06-03 Eli Lilly And Company Anti-viral compounds
US6156924A (en) * 1996-05-06 2000-12-05 Eli Lilly And Company Anti-viral compounds
DE69704180T2 (de) 1996-05-06 2001-08-30 Eli Lilly And Co., Indianapolis Antivirusverbindungen
US6127422A (en) * 1996-05-06 2000-10-03 Eli Lilly And Company Anti-viral method
US6103923A (en) * 1996-05-06 2000-08-15 Eli Lilly And Company Anti-viral compounds
EP0806408B1 (en) * 1996-05-06 2000-12-13 Eli Lilly And Company Anti-viral compounds
US6096917A (en) * 1997-05-02 2000-08-01 Eli Lilly And Company Anti-viral compounds
WO1999031075A1 (en) * 1997-12-16 1999-06-24 Warner-Lambert Company 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
US6605623B1 (en) 1998-12-18 2003-08-12 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU7353300A (en) 1999-09-08 2001-04-10 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
KR20020073574A (ko) 2000-02-02 2002-09-27 워너-램버트 캄파니 피지선 장애 치료용 콜레스테롤 에스테르 및 왁스에스테르 합성 이중 억제제
US6175034B1 (en) 2000-04-10 2001-01-16 Eli Lilly And Company Anti-viral compounds
GB2368579A (en) * 2000-10-31 2002-05-08 Parke Davis & Co Ltd Azole pharmaceutical agents
MXPA03006666A (es) 2001-01-25 2004-05-31 Guilford Pharm Inc Compuestos de union de ciclofilina carbociclicos trisubstituidos y su uso.
US20040072903A1 (en) * 2001-05-08 2004-04-15 Auerbach Bruce Jeffrey Carboxyalkylether-acat inhibitors combinations
US7173151B2 (en) * 2003-02-27 2007-02-06 Sanofi-Aventisdeutschand Gmbh Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
NZ549721A (en) 2004-03-05 2010-08-27 Univ Pennsylvania Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects
EP1976513B1 (en) * 2006-01-06 2016-08-24 Sunovion Pharmaceuticals Inc. Cycloalkylamines as monoamine reuptake inhibitors
EP2066329B1 (en) 2006-09-15 2017-09-06 Reviva Pharmaceuticals, Inc. Synthesis, methods of using, and compositions of cyclobutylmethylamines
CL2007002958A1 (es) * 2006-10-12 2008-05-09 Epix Delaware Inc Compuestos derivados de heteroaril-carboxamida, antagonistas del receptor de quimioquina; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades tales como rechazo de transplante de organos, artritis reumatoidea, lupus, entr
US20080161279A1 (en) * 2006-12-21 2008-07-03 Wisler Gerald L Methods of Treating Obesity
KR20100102646A (ko) 2007-12-11 2010-09-24 가부시키가이샤 사이토파스파인더 카르복스아미드 화합물 및 케모카인 수용체 길항제로서의 이의 용도
WO2010039801A2 (en) 2008-10-02 2010-04-08 The J. David Gladstone Institutes Methods of treating hepatitis c virus infection
WO2012003501A2 (en) 2010-07-02 2012-01-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
IN2014DN08604A (da) 2012-03-22 2015-05-22 Univ Michigan
WO2015117147A1 (en) 2014-02-03 2015-08-06 Quadriga Biosciences, Inc. Beta-substituted beta-amino acids and analogs as chemotherapeutic agents
US9394236B2 (en) 2014-02-03 2016-07-19 Quadriga Biosciences, Inc. β-substituted γ-amino acids and analogs as chemotherapeutic agents
AU2015320358B2 (en) 2014-09-26 2020-05-14 Millendo Therapeutics, Inc. Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl) methyl)urea hydrochloride and compositions, methods and kits related thereto
US20160287565A1 (en) 2015-04-06 2016-10-06 Millendo Therapeutics, Inc. Combination therapy for treating disorders associated with excess cortisol production
CA2994404C (en) 2015-08-03 2020-12-08 Quadriga Biosciences, Inc. Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
EP4188372A1 (en) 2020-07-29 2023-06-07 Amryt Pharmaceuticals Inc. Lomitapide for use in methods of treating hyperlipidemia and hypercholesterolemia in pediatric patients
CN112441941B (zh) * 2020-12-03 2022-08-02 浙江荣耀生物科技股份有限公司 一种1-(4-氨基苯基)环戊基甲腈的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852343A (en) * 1970-07-22 1974-12-03 Labofina Sa A process for the production of benzene carboxylic acids from ethyl substituted benzens
EP0049538A3 (de) * 1979-07-14 1982-10-13 Bayer Ag Verwendung von Thioharnstoffderivaten als Arzneimittel bei der Behandlung von Fettstoffwechselstörungen
DE2945530A1 (de) * 1979-11-10 1981-06-04 Chemische Werke Hüls AG, 4370 Marl Harnstoffe mit cyclischen substituenten, ihre herstellung und verwendung als herbizide
GB2080808B (en) * 1980-01-25 1984-01-04 Reanal Finomvegyszergyar Process for the preparation of n-aryl-n-(mono- or disubstituted)-urea derivatives
US4387105A (en) * 1982-01-26 1983-06-07 American Cyanamid Company Methods of treating atherosclerosis with dialkylureas and dialkylthioureas
US4623662A (en) * 1985-05-23 1986-11-18 American Cyanamid Company Antiatherosclerotic ureas and thioureas
US4397868A (en) * 1982-01-26 1983-08-09 American Cyanamid Company Method of treating atherosclerosis with trisubstituted ureas
IE61716B1 (en) * 1987-06-02 1994-11-30 Warner Lambert Co Antihyperlipidemic and antiatherosclerotic urea compounds

Also Published As

Publication number Publication date
IE64603B1 (en) 1995-08-23
DE69012116T2 (de) 1994-12-22
ZA904231B (en) 1992-02-26
AU5675990A (en) 1991-01-07
WO1990015048A1 (en) 1990-12-13
EP0474733A1 (en) 1992-03-18
IE901983A1 (en) 1991-01-02
ATE110713T1 (de) 1994-09-15
PT94231A (pt) 1991-02-08
IE901983L (en) 1990-12-01
JP2799242B2 (ja) 1998-09-17
US5015644A (en) 1991-05-14
JPH04505617A (ja) 1992-10-01
CA2054209A1 (en) 1990-12-02
EP0474733B1 (en) 1994-08-31
CA2054209C (en) 2002-01-15
DE69012116D1 (de) 1994-10-06

Similar Documents

Publication Publication Date Title
ZA904231B (en) Antihyperlipidemic and antiatherosclerotic urea compounds
IE881380L (en) Antiatherosclerotic ureas
DE68906940D1 (de) Antihyperlipidemische und antiatherosclerotische verbindungen und zusammensetzungen.
ES2060682T3 (es) N-((fenil(2,6-disubstituido))-n'-aril)ureas como agentes antihipercolesterolemicos y antiateroscleroticos.
ES2056992T3 (es) N-((fenil(2,6-disubstituido))-n'-diarilalquil)ureas como agentes antihiperlipidemicos y antiateroscleroticos.
BR8703425A (pt) Conjunto para o amortecimento de vibracoes
DK0525123T3 (da) Antiatherosklerotiske og antithrombotiske 1-benzopyran-4-oner og 2-amino-1,3-benzoxazin-4-oner
TR200002480T2 (tr) İzaşemi tedavisi için guanidin türevleri
IT8821542A0 (it) Composti attivi come inibitori della biosintesi del colesterolo.
BR8806948A (pt) Conjunto para o amortecimento de vibracoes
NO903593L (no) Anvendelse av omsetningsprodukter av alkenylspirobislaktoner og aminer som parafindispergatorer.
TR24539A (tr) Yumusak biyolojik dokularin elestikliginin bastir- madan akuestik sekilde denenme
GR3001602T3 (en) N-((2,6-disubstituted)phenyl)-urea and carbamate inhibitors of acyl-coa:cholesterol acyl-transferase
NO885670L (no) Fortilsetning og for som inneholder denne tilsetning.
DK158972C (da) Farmaceutiske formuleringer indeholdende benzothiophenderivater
PT99435A (pt) Processo para a preparacao de derivados de amino-sulfonil-ureia e de composicoes farmaceuticas que os contem
DK35483A (da) Expressionsvectorer for catechol-2,3-oxygenase, de vundne enzymer og deres anvendelse
DK0386487T3 (da) N-(Substitueret aryl)-N-(substitueret alkoxy)-urinstoffer og -thiourinstoffer som antihypercholesterolæmiske og antiatherosclerotiske midler
NO883063L (no) Fremgangsmaate, anordning og sett for maaling av vevplasminogenaktivator-aktivitet.
DE3670997D1 (de) Anordnung bei foerderbaendern.
PT86611A (pt) Process for the manufacture of n,n-(dibenzohexatrienylene)ureas
DK349188D0 (da) Fremgangsmaade til fremstilling af urinstoffer, carbamater og carbamatderivater
BR8705824A (pt) Processo e instalacao para concentracao de uma solucao de ureia e solucao de ureia obtida pelos mesmos
FI903473A7 (fi) Menetelmä uusien, typpeä ja rikkiä sisältävien heterosyklisten yhdisteiden valmistamiseksi
DE58906412D1 (de) Anordnung zum Dämpfen von Schwingungen elastischer Systeme.